glp-1 agonist drug interactions and Telehealth Weight Loss Care Targeting GLP-1, GIP & GCG

Acute kidney injury has occurred, often in the context of severe dehydration from gastrointestinal side effects, emphasising the importance of maintaining adequate hydration

The release of proglucagon causes the liver to make glucose (gluconeogenesis converting protein to glucose) as well as to convert fatty acids into ketone bodies

In a randomized trial using PET-MRI to assess carotid plaque inflammation, semaglutide did not show a significant difference versus placebo on the prespecified primary plaque-inflammation endpointslikely influenced by low baseline inflammatory burden in a well-treated population. How to interpret this: Imaging studies like this are helpful for understanding mechanisms and terminology (e.g., atherosclerotic inflammation, PET-MRI plaque imaging), but they do not establish semaglutide as a direct vascular inflammation imaging reducer in general clinical use based on current evidence. 5) They Improve Kidney Outcomes in High-Risk Populations (Semaglutide) By improving glycemic control and metabolic stress, GLP-1 therapies can reduce kidney risk in susceptible patients

We don't have evidence of that yet

Insured pricing will start as low as $25 per month, Amazon said

doi: 10.1016/S2213-2600(19)30198-5, 2